Hoyer D
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.
Neuropsychopharmacology. 1990 Oct-Dec;3(5-6):371-83.
Serotonin (5-hydroxytryptamine [5-HT]) receptors can be classified either pharmacologically, into 5-HT1, 5-HT2, 5-HT3 and 5-HT4 receptors, or functionally, into G-protein-coupled receptors (5-HT1, 5-HT2, and 5-HT4) and ligand-gated ion channels (5-HT3). This article concentrates on the pharmacology, distribution, receptor-effector coupling, possible subtypes, and species differences of 5-HT3 receptors, which are equivalent to Gaddum and Picarelli's 5-HT-M receptor. Also presented here are some of the prominent features of the recently characterized 5-HT4 receptor. Although pharmacologic similarities have been suggested between 5-HT-M and 5-HT4 receptors (some potent 5-HT3 antagonists are active, with lower potency, at 5-HT4 receptors), it is clear that 5-HT4 receptors are different from 5-HT-M receptors.
血清素(5-羟色胺[5-HT])受体可从药理学角度分为5-HT1、5-HT2、5-HT3和5-HT4受体,也可从功能角度分为G蛋白偶联受体(5-HT1、5-HT2和5-HT4)和配体门控离子通道(5-HT3)。本文着重探讨5-HT3受体的药理学、分布、受体-效应器偶联、可能的亚型以及种属差异,5-HT3受体等同于加德姆和皮卡雷利的5-HT-M受体。本文还介绍了最近鉴定出的5-HT4受体的一些突出特征。尽管有人提出5-HT-M和5-HT4受体在药理学上存在相似性(一些强效5-HT3拮抗剂在5-HT4受体上也有活性,但效力较低),但很明显5-HT4受体与5-HT-M受体不同。